Overview

A Study of GWP42006 in People With Focal Seizures - Part B

Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
To investigate the potential antiepileptic effects of GWP42006 as add-on therapy in subjects with inadequately controlled focal seizures.
Phase:
Phase 2
Details
Lead Sponsor:
GW Research Ltd